Not applicableEnded earlyNCT01359410What this trial is testingReinforced Staple Line on Leak Rate in Distal PancreatectomyWho this might be right forPancreatic Neoplasms Washington University School of Medicine 112
Testing effectiveness (Phase 2)Active Not RecruitingNCT03600233What this trial is testingStudy of CVM-1118 for Patients With Advanced Neuroendocrine TumorsWho this might be right forNeuroendocrine TumorsPancreatic Neuroendocrine TumorGastro-enteropancreatic Neuroendocrine Tumor+2 more TaiRx, Inc. 34
Very early researchWithdrawnNCT03623984What this trial is testingMolecular-Guided Surgery for Pancreatic and GI Neuroendocrine CancersWho this might be right forNeuroendocrine Carcinoma of PancreasCarcinoid University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT00041808What this trial is testingMagnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverWho this might be right forMetastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more FeRx 20
Not applicableLooking for participantsNCT06523582What this trial is testingGenetic Bases of Neuroendocrine Neoplasms in Mexican PatientsWho this might be right forNeuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of Lung+23 more Universidad Nacional Autonoma de Mexico 750
Testing effectiveness (Phase 2)Study completedNCT00019331What this trial is testingVaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsWho this might be right forColorectal CancerEndometrial CancerHead and Neck Cancer+6 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Post-approval studies (Phase 4)Study completedNCT01525550What this trial is testingThe Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine TumorsWho this might be right forWell-differentiated Pancreatic Neuroendocrine Tumor Pfizer 106
Not applicableLooking for participantsNCT07124000What this trial is testingDESTINY-PANTUMOUR04Who this might be right forAdenocarcinoma (NOS)Anal CancerBladder Cancer+24 more AstraZeneca 100
Not applicableApproved For MarketingNCT03906331What this trial is testingExpanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) ActivationWho this might be right forNon Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+4 more Eli Lilly and Company
Testing effectiveness (Phase 2)Study completedNCT00869050What this trial is testingCapecitabine and Temozolomide for Neuroendocrine CancersWho this might be right forNeuroendocrine Tumors Columbia University 41
Testing effectiveness (Phase 2)Looking for participantsNCT01174121What this trial is testingImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic CancerWho this might be right forMetastatic Colorectal CancerMetastatic Pancreatic CancerMetastatic Ovarian Cancer+2 more National Cancer Institute (NCI) 332
Early research (Phase 1)Study completedNCT02009449What this trial is testingPegilodecakin (LY3500518) in Participants With Advanced Solid TumorsWho this might be right forMelanomaProstate CancerOvarian Cancer+6 more Eli Lilly and Company 353
Testing effectiveness (Phase 2)Study completedNCT00131911What this trial is testingSorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+7 more National Cancer Institute (NCI) 93
Testing effectiveness (Phase 2)Ended earlyNCT02273752What this trial is testingPharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerWho this might be right forEstrogen Receptor-positive Breast CancerGastrinomaGlucagonoma+16 more Emory University 2
Testing effectiveness (Phase 2)Looking for participantsNCT06472388What this trial is testingEverolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine TumorsWho this might be right forNeuroendocrine TumorsProgressionNeuroendocrine Tumor Grade 1+4 more AC Camargo Cancer Center 100
Early research (Phase 1)Study completedNCT01351103What this trial is testingLGK974 in Patients With Malignancies Dependent on Wnt LigandsWho this might be right forPancreatic CancerBRAF Mutant Colorectal CancerMelanoma+5 more Novartis Pharmaceuticals 185
Not applicableUnknownNCT04134832What this trial is testingStudy of Pancreatic Neuroendocrine Tumors and Carcinomas in Alsace RegionWho this might be right forPancreatic Neuroendocrine Tumor University Hospital, Strasbourg, France 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT01824875What this trial is testingTemozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+4 more ECOG-ACRIN Cancer Research Group 144
Testing effectiveness (Phase 2)Ended earlyNCT03829501What this trial is testingA Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced MalignanciesWho this might be right forSquamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more Kymab Limited 222